ES541574A0 - Un metodo para producir una hidrioma de ser humano.ser humano productor de anticuerpos antitetanicos. - Google Patents

Un metodo para producir una hidrioma de ser humano.ser humano productor de anticuerpos antitetanicos.

Info

Publication number
ES541574A0
ES541574A0 ES541574A ES541574A ES541574A0 ES 541574 A0 ES541574 A0 ES 541574A0 ES 541574 A ES541574 A ES 541574A ES 541574 A ES541574 A ES 541574A ES 541574 A0 ES541574 A0 ES 541574A0
Authority
ES
Spain
Prior art keywords
human
hydrioma
antiethaneous
antibodies
produce
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES541574A
Other languages
English (en)
Other versions
ES8702791A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitsubishi Tanabe Pharma Corp
Original Assignee
Green Cross Corp Japan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Green Cross Corp Japan filed Critical Green Cross Corp Japan
Publication of ES541574A0 publication Critical patent/ES541574A0/es
Publication of ES8702791A1 publication Critical patent/ES8702791A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/081—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from DNA viruses
    • C07K16/085—Herpetoviridae, e.g. pseudorabies virus, Epstein-Barr virus
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1267—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria
    • C07K16/1282—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria from Clostridium (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/08—Clostridium, e.g. Clostridium tetani
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/40—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum bacterial
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/34—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against blood group antigens
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C12N5/12—Fused cells, e.g. hybridomas
    • C12N5/16—Animal cells
    • C12N5/163—Animal cells one of the fusion partners being a B or a T lymphocyte
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/948—Microorganisms using viruses or cell lines

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Mycology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Cell Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
ES541574A 1984-03-28 1985-03-26 Un metodo para producir una hidrioma de ser humano.ser humano productor de anticuerpos antitetanicos. Expired ES8702791A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP59060061A JPS60203186A (ja) 1984-03-28 1984-03-28 ヒト−ヒトハイブリド−マ

Publications (2)

Publication Number Publication Date
ES541574A0 true ES541574A0 (es) 1987-01-16
ES8702791A1 ES8702791A1 (es) 1987-01-16

Family

ID=13131190

Family Applications (1)

Application Number Title Priority Date Filing Date
ES541574A Expired ES8702791A1 (es) 1984-03-28 1985-03-26 Un metodo para producir una hidrioma de ser humano.ser humano productor de anticuerpos antitetanicos.

Country Status (5)

Country Link
EP (1) EP0157574B1 (es)
JP (1) JPS60203186A (es)
KR (1) KR850006705A (es)
DE (1) DE3574601D1 (es)
ES (1) ES8702791A1 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8426464D0 (en) * 1984-10-19 1984-11-28 Technology Licence Co Ltd Monoclonal antibodies
JP2599123B2 (ja) * 1985-12-28 1997-04-09 萩原 義秀 新規なヒトｂセル・リンパ芽球細胞変異株
US5001065A (en) * 1987-05-27 1991-03-19 Cetus Corporation Human cell line and triomas, antibodies, and transformants derived therefrom
US5126259A (en) * 1987-12-24 1992-06-30 Takeda Chemical Industries, Ltd. Human b. lymphoblastoid cell, hybridoma, antibody and production of antibody
JPH0249597A (ja) * 1988-04-27 1990-02-19 Kimiyoshi Tsuji モノクローナル抗体及びその利用方法
CA2028815A1 (en) * 1989-03-20 1990-09-21 Yuko Mizuno Human monoclonal antibodies having reactivity with pseudomonas aeruginosa, cells capable of producing the same, methods for production thereof and pharmaceutical preparations thereof
EP0562132B1 (en) * 1992-03-23 1998-06-03 SCHWEIZERISCHES SERUM- & IMPFINSTITUT BERN Monoclonal anti-tetanus toxin antibodies and pharmaceutical compositions containing them
JP2721817B2 (ja) * 1995-05-15 1998-03-04 萩原 義秀 ヒト／ヒト・ハイブリドーマ及びその生産する抗体

Also Published As

Publication number Publication date
EP0157574A3 (en) 1986-06-18
DE3574601D1 (de) 1990-01-11
EP0157574A2 (en) 1985-10-09
KR850006705A (ko) 1985-10-16
EP0157574B1 (en) 1989-12-06
JPS60203186A (ja) 1985-10-14
ES8702791A1 (es) 1987-01-16

Similar Documents

Publication Publication Date Title
ES545892A0 (es) Un metodo de producir un cigarrillo
BR8800694A (pt) Metodo para produzir engrenagens anulares
ES542028A0 (es) Un metodo de producir una composicion de interleuquina-2
ES516254A0 (es) "un metodo de producir derivados de 1-sulfo-2-oxoazetidina".
MX160465A (es) Mejoras a metodo para fabricar un marbete
GB8428321D0 (en) Production of antibodies
ES541867A0 (es) Un metodo para determinar la presencia de un determinante antigenico de interleuquina-2-en una muestra.
DE3577546D1 (de) Herstellungsverfahren von methylmethacrylaten.
ES514814A0 (es) Un metodo para la produccion de una fraccion proteinica enriquecida.
ES509132A0 (es) "un metodo para producir un heterofilamento".
ES526247A0 (es) Un metodo de produccion de una preparacion de enzima inmovilizado
IT1140050B (it) Produzione di anticorpi monoclonali umani mediante ibridomi umani
DE3583636D1 (de) Herstellungsverfahren von kaliumhydroxyd.
ES532509A0 (es) Un metodo de preparar dihidrobenzopirrolbenzodiazepinas
ES513027A0 (es) "metodo de producir nuevas lineas de celulas t humanas".
ES520029A0 (es) Metodo de producir ferrosilicio.
ES544991A0 (es) Un metodo para producir una composicion de gamma-interferon de ser humano.
ES541574A0 (es) Un metodo para producir una hidrioma de ser humano.ser humano productor de anticuerpos antitetanicos.
ES546167A0 (es) Un metodo para aumentar la funcionalidad de una resina epo- xidica
MX164848B (es) Metodo mejorado para producir escoria
ES548109A0 (es) Un metodo de preparacion de n,n-di-n-propil-4-hidroxi-3- metanosulfonamido-fenetilamina
NO854794L (no) Fremgangsmaate for reell-tids klokkesynkronisering.
ES540907A0 (es) Un metodo de producir una composicion farmaceutica estabili-zada
ES522585A0 (es) Un metodo para determinar la presencia de una neoplasia.
ES520929A0 (es) Un metodo de producir un organo-siloxano.

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19960603